Claim a Free Sample
Get a preview with key statistics, projections, and trends for this report. Ideal for quick insights.
Send Me a SampleNeed full access?
Purchase ReportMarket Size & Trends
The size of the global pharmaceutical transportation services market was calculated at USD 78.61 billion in the year 2024 and is expected to rise with a CAGR of 7.71% during the forecast period 2025-2030. The industry's growth primarily comes as a result of rising demand for temperature-sensitive biologics, vaccines, and cell and gene therapies.
Pharmaceutical Transportation Services Market
Size, byProduct, 2024 - 2032{USD Billion}
CAGR: 7.71%
pharmaceutical transportation services market is expected to rise with a CAGR of 7.71% during the forecast period 2025-2030. request a free sample copy
Pharmaceutical Transportation Services Market
Size, byProduct, 2024 - 2032{USD Billion}
pharmaceutical transportation services market is expected to rise with a CAGR of 7.71% during the forecast period 2025-2030. request a free sample copy
Key Highlights
- North America pharmaceutical transport services market held the highest share of 47.40% in 2024.
The U.S. pharmaceutical transportation services market is led by the nation's highly evolved regulatory environment (FDA, GDP, GMP) which requires strict compliance with cold chain regulations.
Segmented by type, the biopharmaceuticals segment held the highest market share in 2024, at 60.61%.
According to the type of services, the air freight sector dominated the market in 2024.
By supply chain segment, the non-cold chain logistics segment held the largest market share in 2024.
Tighter regulatory demands for drug safety in transit are compelling businesses to implement customized logistics solutions. Increased global clinical trials and international pharmaceutical trade are also compelling the demand for dependable, compliant transport networks.
The expansion of pharmaceutical transport services is fueled mainly by increased demand for high-value, temperature-sensitive pharmaceuticals. Biologics, cell and gene therapies, and emerging vaccines impose rigorous handling demands in transit. Drug manufacturers are more and more outsourcing logistics to specialized partners that can provide precise environmental conditions. Globalization of drug production resulted in more sophisticated cross-border supply chains across various countries. Rising frequency of cross-border shipments results in a strong need for time-critical, compliant transport solutions. Healthcare providers and pharmacies demand real-time visibility to drug deliveries. Temperature control failure can make entire shipments worthless, compelling stakeholders to invest in smarter and safer transport systems. Governments and regulatory bodies have put tougher regulations on pharmaceuticals handling, and it places pressure on logistics providers to enhance their abilities.
Pharmaceutical supply chain globalization is also among the drivers of the development of transportation services. The growth in the manufacturing of pharmaceuticals, especially in emerging economies, has brought increased complexity into supply chains, giving rise to an urgent necessity for efficient and dependable transport options. International trade in medicines is on the rise because of increased demand for cheap drugs and speedier access to new therapies, necessitating logistics networks that can handle these varied and time-critical shipments. Transportation companies have to deal with sophisticated regulatory frameworks, such as drug-specific requirements and customs rules, while maintaining compliance with import and export regulations. The sophistication leads to a greater need for advanced logistics services that can handle multiple regulatory issues, provide end-to-end visibility, and offset the risks inherent in global trade. As a result, the development of cross-border pharmaceutical trade is fueling the demand for sophisticated and adaptable transportation services capable of fulfilling these changing requirements.
Report Coverage & Deliverables
- Competitive benchmarking
- Historical data & forecasts
- Company revenue shares
- Regional opportunities
- Latest trends & dynamics
Opportunity Analysis
The pharmaceutical transport services market is growing as a result of the greater adoption of individualized medicine and gene therapies. These new treatments tend to be more complex, requiring sophisticated handling, transport, and storage, making the need for high-quality logistics providers. The trend toward individualized patient care results in more frequent and smaller shipments, which presents the chance for transport companies to serve niche requirements such as home delivery of expensive therapies or expedited shipment for life-restoring treatments.
The increasing emphasis on environmental sustainability in the pharmaceutical supply chain is opening up new possibilities. Pharmaceutical transport service providers are being asked to reduce their carbon footprint and green their logistics more and more. This involves using eco-friendly transportation equipment, reducing routes to save fuel, and going for environmentally friendly packaging. Companies that emphasize sustainability will not only be keeping up with the larger industry-wide trend toward going green, but they will also enjoy cost savings and enhanced customer loyalty.
Technological Advancements
The technology environment is evolving quickly, driven by the industry's increasing demand for precision, velocity, transparency, and compliance. Third-party logistics providers are pushing ahead from conventional models to embrace integrated digital environments that provide greater visibility and control throughout the supply chain. Cloud-based platforms are facilitating centralized planning and real-time tracking, while AI and data analytics are enhancing decision-making in route optimization, demand forecasting, and risk management. Automation and robotics are streamlining packaging and warehouse operations to preserve temperature integrity and minimize human error. At the same time, technologies such as blockchain are increasing traceability and security, dealing with risks associated with counterfeiting and regulatory risks. This changing scenario is indicative of a move toward networked, intelligent infrastructure that is capable of dealing with sophisticated pharmaceutical delivery requirements in disparate geographies.
Pricing Analysis
The industry pricing landscape is shifting towards more flexible, client-focused models based on complexity, regulation, and specialization in logistics. Business models are shifting away from entirely cost-driven models towards ones that focus on the value of the service, outcome guarantees, and flexibility for various shipment requirements. Need for high-touch solutions such as cold chain compliance, real-time visibility, and risk-managed global shipments is pushing the implementation of pricing models that recognize precision and reliability. This change is a manifestation of a larger change in logistics collaborations, in which pricing is not only an economic contract, but also a strategic blueprint that integrates delivery performance, patient safety, and regulatory requirements.
Type Insights
The biopharmaceuticals segment took the highest market share in 2024, at 60.61%. Growth in the segment has been attributed mainly to the increasing demand for temperature-sensitive therapies including monoclonal antibodies, cell and gene therapies, and recombinant proteins that necessitate strict cold chain logistics. Broadening R&D pipelines, particularly in personalized medicine and biologics, have driven the volume and complexity of these shipments higher.
ApplicationRecord. Regulatory demands for temperature integrity and quality assurance during transportation further necessitate specialized transport solutions.
Pharmaceuticals segment is expected to see the fastest expansion as a result of the continuing move towards personalized medicine, rising regulatory clearances, and a wider expansion of healthcare penetration across the world. These are likely to demand more effective transport of both active pharmaceutical ingredients (APIs) as well as finished dosage forms, especially in developing markets.
Services Insights
The air freight segment of the market dominated in 2024. The increase in the segment can be explained by its speed, global connectivity, and capacity to transport temperature-sensitive products. Air transport provides speedy transportation, which is very important for biopharmaceuticals and other time-critical medicines, and minimizes the risk of product deterioration. Furthermore, the wide global connectivity of air freight provides effective international distribution, while specialized cold chain solutions provide compliance with temperature control specifications.
The sea freight segment is expected to experience profitable growth throughout the forecast period. The segment's growth primarily owes to its affordability and ability to transport massive volumes of pharmaceutical products. Sea freight is generally less expensive than air freight and can prove to be an encouraging way to transport bulk pharmaceutical products with longer shelf lives and smaller time sensitivities. Growing need for international distribution, especially to developing markets, also adds strength to the attractiveness of sea freight.
Supply Chain Insights
The non-cold chain logistics sector led by the market in 2024 because it is more universal in scale, inexpensive, and less complex than cold chain logistics. Most pharmaceuticals, including traditional small-molecule drugs, need temperature-insensitive transportation and are thus compatible with non-cold chain logistics. It enjoys the increasing volume of generic pharmaceuticals and established pharmaceutical drugs, which tend to have longer shelf lives and are less sensitive to the environment.
Cold chain logistics segment is estimated to register the highest CAGR between 2025 and 2030. The growth is fueled because of the demand for temperature-sensitive drugs, especially biopharmaceuticals, vaccines, and gene therapies, which is on the rise. These drugs need exacting temperature control along the supply chain to sustain their efficacy, necessitating specialty logistics solutions. As the world biopharmaceutical market grows, demand for cold chain services will increase, particularly in emerging markets where there is growing access to healthcare.
Regional Insights
North America pharmaceutical transportation services market captured the largest of 47.40% in 2024 because it has a robust healthcare infrastructure and well-established cold chain networks to facilitate the challenging requirements of pharmaceutical logistics. The region has a high density of precision medicine developers, which fuels higher demand for specialized transportation.
Global Pharmaceutical Transportation Services Market (2024–2030)
| Region | 2024 Market Size (USD Billion) | CAGR (2025–2030) | 2030 Market Size (USD Billion) | Key Growth Drivers |
|---|---|---|---|---|
| Global Total | 78.61 | 7.71% | 123.01 | Growing demand for temperature-sensitive pharmaceuticals, biologics, and vaccines; expansion of global pharma trade. |
| North America | 28.00 | 7.71% | 43.85 | Largest pharmaceutical market, advanced cold chain logistics, high regulatory compliance. |
| Europe | 20.00 | 7.71% | 31.32 | Strong cross-border pharma trade, stringent GDP guidelines, increasing biologics transport. |
| Asia-Pacific | 18.00 | 7.71% | 28.19 | Growing pharma manufacturing base (India, China), rising healthcare needs, investments in logistics infrastructure. |
| Latin America | 6.00 | 7.71% | 9.40 | Increasing pharmaceutical imports, demand for cold chain services, improving regulatory environments. |
| Middle East & Africa | 6.61 | 7.71% | 10.25 | Rising chronic disease burden, increasing access to medications, growing pharma distribution hubs in UAE and South Africa. |
U.S. Pharmaceutical Transportation Services Market Trends
The pharmaceutical transportation services market in the U.S. is driven by the country’s highly developed regulatory landscape (FDA, GDP, GMP) that mandates strict cold chain compliance. In addition, rising pharmaceutical exports and increased outsourcing of logistics operations to specialized providers are further accelerating the market growth.
Europe Pharmaceutical Transportation Services Market Trends
The European pharmaceutical transportation services market is growing. The region has witnessed increasing investments in GDP-compliant cold storage solutions and last-mile delivery options that facilitate sensitive and high-value therapies. The European Medicines Agency (EMA) applies stringent guidelines for compliance, prompting logistics providers to implement real-time temperature monitoring systems and proactive risk prevention approaches.
UK pharmaceutical transportation services market accounted for a considerable share in 2024. Its market growth is underpinned by a robust pharmaceutical supply chain and strong demand for cold chain logistics owing to an active biotech and vaccine industry. The efforts of Brexit have provided additional complexity to cross-border transit, making cold chain efficiency and traceability even more important.
France pharmaceutical transportation services market is fueled by the expanding biologics and vaccine manufacturing industry, as government-supported pharmaceutical production and R&D programs raise the demand for specialized logistics infrastructure.
Germany pharmaceutical transportation services market will grow based on strong biopharma presence and developing clinical trials. A well-established cold chain infrastructure in the country, along with EU regulatory requirements, is driving continued investment in precise logistics.
Asia Pacific Pharmaceutical Transportation Services Market Trends
The pharmaceutical transportation services market Asia Pacificis projected to grow at the fastest CAGR over the forecast period. Market growth is supported by the rise in pharmaceutical manufacturing, vaccine exports, and increasing demand for biologics and CGT. The region is witnessing large-scale investment in temperature-controlled warehouses, IoT-based tracking systems, and express cold chain transportation tailored for personalized therapies.
China pharmaceutical cold chain transport services market is anticipated to register growth during the forecast period. The nation's growth comes as a result of increased development of cold storage and refrigerated transportation infrastructure to satisfy the demand for rising high-precision treatments. Toughening of government regulations on pharmaceutical cold chain compliance also continues to drive GDP-certified logistics investment.
The Japanese market for pharmaceutical transportation services is experiencing remarkable growth during the forecast period. The nation's expansion is attributed to highly developed regulatory compliance, regenerative medicine demand, and high development in the cold chain. Robotic cold storage, AI logistics systems, and RFID-based tracking characterize the nation and place it among the most developed markets for precision medicine logistics.
India pharma transportation services market is experiencing significant growth as a result of growing government support. The "Make in India" initiative by the government is driving the development of indigenous cold chain infrastructure at a rapid pace.
Latin America Pharmaceutical Transportation Services Market Trends
The Latin American pharmaceutical transport services market is expected to develop during the forecast period. The region is developing due to heightened pharmaceutical imports and increased healthcare access. Brazil and similar countries are spearheading investment in cold storage and refrigerated transport. Infrastructure shortages, regulatory differences, and high logistics costs are motivating providers to implement cost-saving, region-focused cold chain strategies.
Brazil pharmaceutical transportation services market is anticipated to grow throughout the forecast period. The nation has a quickly developing biologics and vaccine distribution channel, which requires improved cold chain storage and regulation-led logistics solutions. Healthcare reforms and augmented pharmaceutical trade agreements are boosting global logistics operations.
Key Pharmaceutical Transportation Services Companies Insights
Key players operating in the pharmaceutical transportation services market are undertaking various initiatives to strengthen their presence and increase the reach of their products and services. Strategies such as expansion activities and partnerships are key in propelling the market growth.
Key Pharmaceutical Transportation Services Companies
The following are the leading companies in the pharmaceutical transportation services market. These companies collectively hold the largest market share and dictate industry trends.
- CEVA Logistics
- Cencora Corporation (ICS)
- DB SCHENKER
- Kuehne+Nagel
- Kerry Logistics Network Limited
- Cardinal Health
- McKesson Corporation
- EVERSANA
- Thermo Fisher Scientific
- Knipper Health
- FedEx
- DHL
Recent Developments
-
In March 2025, DHL made an announcement that it was acquiring Cryopdp in order to boost its life sciences and healthcare business. Cryopdp offers shipping, storage, and packaging services to pharmaceutical and biotech firms. This is in an effort to bolster DHL's supply chain solutions.
During June 2024, DHL increased its dedicated logistics services for the life sciences and healthcare industry in France with a long-term strategic partnership with Sanofi. The partnership comprises warehousing, inventory management, picking and packing, and order fulfillment for three strategic locations in France.
Pharmaceutical Transportation Services Market Report Scope
|
Report Attribute |
Details |
|
Market size value in 2025 |
USD 86.08 billion |
|
Revenue forecast in 2030 |
USD 124.81 billion |
|
Growth rate |
CAGR of 7.71% from 2025 to 2030 |
|
Actual data |
2018 - 2024 |
|
Forecast period |
2025 - 2030 |
|
Quantitative units |
Revenue in USD million/billion and CAGR from 2025 to 2030 |
|
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
|
Segments covered |
Type, service, supply chain, region |
|
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
|
Country scope |
U.S.; Canada; Mexico; UK; Germany; France; Italy; Spain; Denmark; Norway; Sweden; India; Japan; China; Australia; South Korea; Thailand; Brazil; Argentina; South Africa; Saudi Arabia; UAE; Kuwait |
|
Key companies profiled |
CEVA Logistics; Cencora Corporation (ICS); DB SCHENKER; Kuehne+Nagel; Kerry Logistics Network Limited; Cardinal Health; McKesson Corporation; EVERSANA; Thermo Fisher Scientific; FedEx; DHL; Knipper Health |
|
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
|
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
Global Pharmaceutical Transportation Services Market Report Segmentation
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, MIR has segmented the global pharmaceutical transportation services market report based on type, services, supply chain, and region.
-
Type Outlook (Revenue, USD Billion, 2018 - 2030)
-
Biopharmaceuticals
-
Vaccines
-
Biosimilars
-
Plasma Derived Products
-
Others
-
-
Pharmaceuticals
-
-
Services Outlook (Revenue, USD Billion, 2018 - 2030)
-
Air Freight
-
Sea Freight
-
Overland
-
-
Supply Chain Outlook (Revenue, USD Billion, 2018 - 2030)
-
Cold Chain Logistics
-
Non-cold Chain Logistics
-
-
Regional Outlook (Revenue, USD Billion, 2018 - 2030)
-
North America
-
U.S.
-
Canada
-
Mexico
-
-
Europe
-
UK
-
Germany
-
France
-
Italy
-
Spain
-
Denmark
-
Norway
-
Sweden
-
-
Asia Pacific
-
Japan
-
China
-
India
-
Australia
-
South Korea
-
Thailand
-
-
Latin America
-
Brazil
-
Argentina
-
-
MEA
-
South Africa
-
Saudi Arabia
-
UAE
-
Kuwait
-
-